These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 20922397
1. Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Hishiki T, Matsunaga T, Sasaki F, Yano M, Ida K, Horie H, Kondo S, Watanabe K, Oue T, Tajiri T, Kamimatsuse A, Ohnuma N, Hiyama E. Pediatr Surg Int; 2011 Jan; 27(1):1-8. PubMed ID: 20922397 [Abstract] [Full Text] [Related]
2. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol. Hiyama E, Hishiki T, Watanabe K, Ida K, Ueda Y, Kurihara S, Yano M, Hoshino K, Yokoi A, Takama Y, Nogami Y, Taguchi T, Mori M, Kihira K, Miyazaki O, Fuji H, Honda S, Iehara T, Kazama T, Fujimura J, Tanaka Y, Inoue T, Tajiri T, Kondo S, Oue T, Yoshimura K. J Clin Oncol; 2020 Aug 01; 38(22):2488-2498. PubMed ID: 32421442 [Abstract] [Full Text] [Related]
3. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. Sasaki F, Matsunaga T, Iwafuchi M, Hayashi Y, Ohkawa H, Ohira M, Okamatsu T, Sugito T, Tsuchida Y, Toyosaka A, Nagahara N, Nishihira H, Hata Y, Uchino J, Misugi K, Ohnuma N, (Japanese Study Group for Pediatric Liver Tumor). J Pediatr Surg; 2002 Jun 01; 37(6):851-6. PubMed ID: 12037748 [Abstract] [Full Text] [Related]
4. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol. Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Oue T, Iehara T, Hoshino K, Koh K, Tanaka Y, Kurihara S, Ueda Y, Onitake Y. J Pediatr Surg; 2016 Dec 01; 51(12):2053-2057. PubMed ID: 27712887 [Abstract] [Full Text] [Related]
5. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99]. Häberle B, Bode U, von Schweinitz D. Klin Padiatr; 2003 Dec 01; 215(3):159-65. PubMed ID: 12778356 [Abstract] [Full Text] [Related]
6. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area. Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M, Committee for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan. J Pediatr Surg; 2004 Feb 01; 39(2):195-8; discussion 195-8. PubMed ID: 14966739 [Abstract] [Full Text] [Related]
7. A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT). Hiyama E, Ueda Y, Onitake Y, Kurihara S, Watanabe K, Hishiki T, Tajiri T, Ida K, Yano M, Kondo S, Oue T, Japanese Study Group for Pediatric Liver Tumor. Pediatr Surg Int; 2013 Oct 01; 29(10):1071-5. PubMed ID: 24026876 [Abstract] [Full Text] [Related]
8. Surgical strategies for unresectable hepatoblastomas. Tajiri T, Kimura O, Fumino S, Furukawa T, Iehara T, Souzaki R, Kinoshita Y, Koga Y, Suminoe A, Hara T, Kohashi K, Oda Y, Hishiki T, Hosoi H, Hiyama E, Taguchi T. J Pediatr Surg; 2012 Dec 01; 47(12):2194-8. PubMed ID: 23217875 [Abstract] [Full Text] [Related]
9. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G. J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943 [Abstract] [Full Text] [Related]
10. Mortality and morbidity in primarily resected hepatoblastomas in Japan: Experience of the JPLT (Japanese Study Group for Pediatric Liver Tumor) trials. Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Oue T, Iehara T, Hoshino K, Koh K, Tanaka Y, Kurihara S, Ueda Y, Onitake Y. J Pediatr Surg; 2015 Dec 20; 50(12):2098-101. PubMed ID: 26388131 [Abstract] [Full Text] [Related]
11. High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99. Häberle B, Maxwell R, Schweinitz DV, Schmid I. Klin Padiatr; 2019 Nov 20; 231(6):283-290. PubMed ID: 31645068 [Abstract] [Full Text] [Related]
12. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. Fuchs J, Wenderoth M, von Schweinitz D, Haindl J, Leuschner I. Cancer; 1998 Dec 01; 83(11):2400-7. PubMed ID: 9840541 [Abstract] [Full Text] [Related]
13. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years. Ismail H, Broniszczak D, Kaliciński P, Dembowska-Bagińska B, Perek D, Teisseyre J, Kluge P, Kościesza A, Lembas A, Markiewicz M. J Pediatr Surg; 2012 Jul 01; 47(7):1331-9. PubMed ID: 22813792 [Abstract] [Full Text] [Related]
14. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94. Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H. Klin Padiatr; 1999 Jul 01; 211(4):305-9. PubMed ID: 10472567 [Abstract] [Full Text] [Related]
15. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. Katzenstein HM, London WB, Douglass EC, Reynolds M, Plaschkes J, Finegold MJ, Bowman LC. J Clin Oncol; 2002 Aug 15; 20(16):3438-44. PubMed ID: 12177104 [Abstract] [Full Text] [Related]
16. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. von Schweinitz D, Byrd DJ, Hecker H, Weinel P, Bode U, Bürger D, Erttmann R, Harms D, Mildenberger H. Eur J Cancer; 1997 Jul 15; 33(8):1243-9. PubMed ID: 9301450 [Abstract] [Full Text] [Related]
17. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, Haas JE, King DR, Liu-Mares W, Sensel MG, Krailo MD. J Clin Oncol; 2000 Jul 15; 18(14):2665-75. PubMed ID: 10894865 [Abstract] [Full Text] [Related]
18. A case of resection under the IVC-atrial venovenous bypass of a hepatoblastoma after intraarterial chemotherapy. Uotani H, Yamashita Y, Masuko Y, Shimoda M, Murakami A, Sakamoto T, Tazawa K, Tsukada K. J Pediatr Surg; 1998 Apr 15; 33(4):639-41. PubMed ID: 9574768 [Abstract] [Full Text] [Related]
19. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A. Cancer; 2002 Feb 15; 94(4):1111-20. PubMed ID: 11920482 [Abstract] [Full Text] [Related]
20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB. Cancer Chemother Pharmacol; 2002 May 15; 49 Suppl 1():S13-20. PubMed ID: 12042984 [Abstract] [Full Text] [Related] Page: [Next] [New Search]